Chemoinformaics analysis of 1,3-DIHYDROXYPENTANE-1,3,5-TRICARBOXYLIC ACID
| Molecular Weight | 236.176 | nRot | 7 |
| Heavy Atom Molecular Weight | 224.08 | nRig | 3 |
| Exact Molecular Weight | 236.053 | nRing | 0 |
| Solubility: LogS | -0.64 | nHRing | 0 |
| Solubility: LogP | -1.665 | No. of Aliphatic Rings | 0 |
| Acid Count | 3 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 27.7775 |
| nHD | 5 | BPOL | 14.6425 |
| QED | 0.316 |
| Synth | 3.516 |
| Natural Product Likeliness | 0.798 |
| NR-PPAR-gamma | 0.012 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.655 |
| HIA | 0.283 |
| CACO-2 | -6.203 |
| MDCK | 0.00651235 |
| BBB | 0.303 |
| PPB | 0.253609 |
| VDSS | 0.37 |
| FU | 0.691793 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.044 |
| CYP2c19-inh | 0.016 |
| CYP2c19-sub | 0.038 |
| CYP2c9-inh | 0.007 |
| CYP2c9-sub | 0.44 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.103 |
| CYP3a4-inh | 0.014 |
| CYP3a4-sub | 0.002 |
| CL | 1.731 |
| T12 | 0.909 |
| hERG | 0.005 |
| Ames | 0.025 |
| ROA | 0.002 |
| SkinSen | 0.202 |
| Carcinogencity | 0.005 |
| EI | 0.936 |
| Respiratory | 0.02 |
| NR-Aromatase | 0.012 |
| Antiviral | No |
| Prediction | 0.899876 |